ReWalk Robotics Ltd. (RWLK)

[StockLogistics]

Insider buys

https://ih.advfn.com/stock-market/NASDAQ/rewalk-robotics-RWLK/stock-news/89271559/statement-of-changes-in-beneficial-ownership-4

Once Medicare reimbursements start, major revenue imo, advertising, promotion, this could be the key reversal in the chart

[StockLogistics]

“7:17a ET 9/28/2022 - Benzinga
ReWalk to Submit First Cases for Medicare Coverage Through Medicare Administrative Contractors

ReWalk Robotics Ltd. (Nasdaq: RWLK) is announcing that the Company will begin submitting Medicare cases following CMS's September 26, 2022, announcement affirming that the MACs have discretion to cover and reimburse for the ReWalk exoskeleton. ReWalk Robotics is actively engaged with CMS in its commitment to evaluate complex advanced technologies like exoskeletons.

This is the latest step in ReWalk's efforts to expand access to the Company's exoskeletons for Medicare beneficiaries with SCI. Studies have shown that the ability to ambulate with an exoskeleton has a profound and beneficial impact on health outcomes for individuals with SCI, including through improved mental health, increased gastrointestinal (GI) function and other improvements on the health consequences of a SCI. ReWalk has prioritized working with payers like Medicare to ensure coverage of and access to exoskeleton technologies for individuals who are paralyzed or disabled due to SCI, so they are able to once again experience the health and well-being benefits of functional ambulation.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”

Medicare reimbursements are the key

[StockLogistics]

“8:00a ET 6/2/2022 - Globe Newswire
ReWalk Robotics Announces Share Repurchase Program

EQNX::TICKER_START (NASDAQ:RWLK), EQNX::TICKER_END ReWalk Robotics Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical technology for people with lower extremity disabilities, today announced that its Board of Directors (the "Board") has approved a program to repurchase up to $8 million of its Ordinary Shares, par value NIS 0.25 per share. The program is subject to receipt of court approval, and ReWalk has filed a motion requesting permission to make purchases for a period of six months following the date of the court's authorization.

"We are pleased to announce this repurchase program to benefit all shareholders at a time when we believe our stock is undervalued," stated Jeff Dykan, Chairman of the Board. "The Board approved the program as part of its ongoing consideration of alternative methods to take advantage of the Company's strong cash position and based on the input of our shareholders. We believe the program represents a prudent use of the Company's capital and signals the Board's confidence in our long-term prospects - with pivotal decisions expected in 2022 regarding coverage in the U.S. and in Germany. We remain committed to utilizing our cash to support growth and maximize shareholder value."

The share repurchase program was unanimously approved by the Board. The Board believes that a share repurchase program at this time is in the best interests of the Company and its shareholders, and will not impact ReWalk's ability to execute its growth plans.

Under the program, share repurchases may be made from time to time using a variety of methods, including open market transactions or in privately negotiated transactions. Such repurchases will be made in accordance with all applicable securities laws and regulations, including restrictions relating to volume, price and timing under applicable law, including Rule 10b-18 under the United States Securities Exchange Act of 1934, as amended (the "1934 Act"). The timing and amount of shares repurchased will be determined by the Company's management, within guidelines to be established by the Board or a committee thereof, based on its ongoing evaluation of ReWalk's capital needs, market conditions, the trading price of the Company's shares, trading volume and other factors, subject to applicable law. For all or a portion of the authorized repurchase amount, ReWalk may enter into a plan compliant with Rule 10b5-1 of the 1934 Act that is designed to facilitate these repurchases.

The repurchase program does not require ReWalk to acquire a specific number of shares, and may be suspended or discontinued at any time. The share repurchases will be funded from available working capital.”

Perfect timing for the buyback announcement in regards to the chart, next Monday was the opportunity so getting this in before that shows they have expert financial management and shareholder interests are a priority to the company. Impressive.

[I-Man]

More Bullshit! I was an original investor, lost all my investment here.

Look at last night's "Shareholder Letter".

These people are like George Economou of former DRYS stock- personal ATM for "Insiders" to get very wealthy:


May 26, 2022

Dear Shareholders,

Thank you for your investment in ReWalk Robotics and your confidence in our life-changing technologies. We are writing to you because this year's Annual Meeting of Shareholders (the "Annual Meeting") will be especially important, as we are closing in on achieving critical milestones to pave the way for broader patient access to our solutions, which we believe will enhance value creation.

Your Board and management team are working hard to continue to create value by pursuing increased access to wearable robotic exoskeletons through expanded reimbursement coverage in the U.S. and Germany. These efforts are catalysts for achieving sustainable growth stemming from our years of thoughtful investment in research, development and innovation. In our view, ReWalk is at an exciting inflection point on the road to broad commercialization.

Our core strategy involves the following:

Adding systemic coverage and reimbursement with the Centers for Medicare and Medicaid ("CMS") and other payers to improve lives and create pathways for individuals to benefit from our technologies


Making meaningful progress on key long-term initiatives, including developing the infrastructure for claims processing post payer approvals and to improve Veterans Affairs ("VA") support post-COVID


Advancing technical developments that expand our addressable markets and allow more effective penetration under existing coverage programs


Expanding the Company product portfolio to achieve faster growth on the path to profitability

Below we outline in further detail the exciting progress to date and our plans for the future.

[StockLogistics]

The product will only get better with time

[StockLogistics]

No chance at .42 it seems, too much upside potential in the near to mid term, (20.00 - 25.00) GLTA

[StockLogistics]

Great stock potential hoping to get in at .42 cents

[StockLogistics]

Gaps at .42 and 1.29 imo

[VEGAS BABY]

G.M. Board, I'm new-I took a position yesterday.
Why is this board so Quiet? Is there another board I'm not aware of?
Ok then well Let's do this.
Jesus is Lord.

[haitianfighter1]

I'm with you on that.. $$volume$$

[Jess070283]

Bids coming in. Looks like it may run hard today!$$$

[I-Man]

Sadly yes, earnings always the same. borderline and insiders sell their free shares into hyped retail buying. They collapse price right back to ZERO line (1.00) area to keep listing in good form for SEC, and continue same old process over and over.. So sad too, because what they have is a life changing device too..

[I-Man]

Sadly yes, earnings always the same. borderline and insiders sell their free shares into hyped retail buying. They collapse price right back to ZERO line (1.00) area to keep listing in good form for SEC, and continue same old process over and over.. So sad too, because what they have is a life changing device too..

[pinkslipjunkie]

looks like you called that out right.

[wochsac]

$RWLK looks to be getting locked up :)

[I-Man]

Political double-speak... Only designation of the product name.... Approval processes start after and can take a long time. NOT FDA approval at all. Read the text.



The FDA has granted Breakthrough Device designation to ReWalk Robotics Ltd's (NASDAQ: RWLK ) ReBoot device.

With this designation, ReWalk will now readily pursue the FDA approval pathway for ReBoot.

The company is finalizing ReBoot's design and development and will proceed to the clinical studies required for FDA clearance application.


WATCH for Insiders selling their preferred shares yet again as always the last several years on news..... Personal ATM machine.

[I-Man]

LOL, UNLESS they shortsell into it like always before. A personal ATM for Insiders is all it has been for several years.

DON'T look at afterhours as it is extremely thin and able to be manipulated easily on small volumes...

[MADDSTACKER]

Gapper in the am

[S3lfMade]

Nice news ... Sister product approved, original fda approval came on 2019.

[I-Man]

Another dillution/offering ! That's all these people do. Personal ATM at shareholders' expense for years...

[1sdestiny]

Yeah but this is a direct offering. Not public. Maybe set up to short for the tuts to cover but it dropped considerably lower than what they are bought it for.

Hopefully the dropped it to pick up cheap shares before the german surpreme court decision

[Phill-lecup]

Wouldn't anything bellow offering be a good entry?

[BooDog]

Offering priced @ $2.035 ex @ $2. Typical gap & trap and run up for an offering. Was watching for a reset on this one too, looks like it's happening.


https://ih.advfn.com/stock-market/NASDAQ/rewalk-robotics-RWLK/stock-news/86141204/rewalk-robotics-announces-32-5-million-registered


GLTA

[boston127]

Up again today. Hit $2.78.

The shares are changing hands. Going from those who sold yesterday to those who are buying today. Charts show next stop: $3.76 - $4.12 by next week.

[Termite7]

What would be better? Thanks!!!

[boston127]

Very good volume, maintained movement UP.

Looks like an UP day tomorrow. Seems like someone knows something good is happening here. Will hold and continue buying on dips. This was $20 just 3 years ago, and $5 just 1 year ago, and they had far less going on.

Would like to see sub $2 , maybe even sub $1.50, and would then pile on.

[$oldier Hard]

Making some sense with the volume. I only have a few left so just leaving those for a just in case.

[$ubmachine]

Unbelievable! Next step ahead!
German Government Approval Boosts ReWalk Robotics Ltd. (NASDAQ:RWLK)
https://www.twst.com/news/german-government-approval-boosts-rewalk/

[$ubmachine]

Reddits & Stocktwits on it... This will squeeze!

[Phill-lecup]

Yeah i got out too, 1.84 to 2.38. Agree with your re-entry

[dirtydozen911]

i`m out.....up .70 / share from tues on about 10k....good enough!!

should be able to buy back in around $2 a few days from now.

$$$$$$$$$$$$$$$$$$$$ RWLK $$$$$$$$$$$$$$.....glta

[$oldier Hard]

Really liking the daily volume in this one.

[Phill-lecup]

Just checking in

[retireat40]

Not really

[Termite7]

Great buying opportunity!!!

[traderzzfun]

"Important milestones" ahead! New CEO Interview out with Larry Jasinski:
https://www.twst.com/news/rewalk-robotics-nasdaqrwlk-ceo-interview/

Keys:
"Those soft exosuits will eventually be a formula for us to provide these wearable robotics for multiple sclerosis, and we hope, for Parkinson’s. We still have to build their data for more applications. For stroke, we’ve already brought it to market for use in the clinic.

Our next version of the product is a product you’d use at home. You could use it for a period of therapy, and perhaps longer term for patients who need it for a long cycle of use.”

“The largest demand is currently in Germany, because their coverage is the most complete. So in 2020 sales, that will probably be our biggest country. The U.S. is not that far behind, because we already have the national coverage policy with the VA. So veterans in the United States have access to these products.

Larry Jasinski states that the current high expectations for ReWalk Robotics (NASDAQ:RWLK) are fueled by the anticipation of further government support:

“Our second half of this year is looking at how much COVID allows us back into the market, which we expect, at the current rate of vaccination that our employees and our customers and our clinics are having, is going to be pretty good.

We’ve done a few things. In the early part of this year and late last year, we did a lot of work to solidify our balance sheet. We’ve done some additional capital raises. We’ve reduced our burn. We’ve eliminated all of our long-term debt. So we believe we have enough of a runway now to take us to breakeven operations.

We have important milestones that will affect us, including a German Federal Court decision, which may even broaden coverage in Germany if it’s positive. That will occur probably sometime this year.”

[moe_the_gyp01]

https://stocktwits.com/symbol/RWLK

https://investorplace.com/2021/09/rwlk-stock-short-squeeze-watch-what-to-know-as-rewalk-robotics-investors-burn-the-shorts/

[moe_the_gyp01]

https://stocktwits.com/symbol/RWLK

[DarkPool]

Letz go

[MACH1351CJ]

Why is this going wild now?

[Yooo]

Thoughts on the last $ raise at $3.66 per share and currently a strong balance sheet of over 60 million in cash on hand… are we a good buy today under $1.50 per share? MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 26, 2021 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced private placement of 10,921,502 ordinary shares and warrants to purchase up to 5,460,751 ordinary shares, at a purchase price of $3.6625 per share and associated warrant, that was priced “at-the-market” under Nasdaq rules and resulted in gross proceeds of approximately $40.0 million before the deduction of placement agent fees and expenses and estimated offering expenses payable by the Company. The warrants have a term of five and one-half years, are exercisable immediately and have an exercise price of $3.60 per ordinary share. https://finance.yahoo.com/news/rewalk-robotics-announces-closing-40-174100142.html

[Yooo]

65 mill market cap with 65 mill in cash.. the PPS should be double (over $3) from where we are today. IMO

[midastouch017]

ReWalK Q2 2021 Earnings Preview

Aug. 08, 2021 9:39 PM ETReWalk Robotics Ltd. (RWLK)

By: Gaurav Batavia, SA News Editor

ReWalK (NASDAQ:RWLK) is scheduled to announce Q2 earnings results on Monday, August 9th, before market open.

The consensus EPS Estimate is -$0.06 (+72.7% Y/Y) and the consensus Revenue Estimate is $1.41M (-15.6% Y/Y).

Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates have seen 1 upward revision and 0 downward.

[I-Man]

I have been researching MNMD as they just announced Phase 1 trials in Switzerland and seem to be the real deal to help people...

[SC8]

Amen. This fraud of company only sells stock, not product. If RWLK products performed anything close to as advertised, they'd be profitable. Rich and middle class people get disabled too. Don't need insurance approval to sell to rich and middle class disabled people. What would you pay for ease of mobility if disabled? Rich could pay cash and middle class could lease finance. So gotta go with Occam on this one and conclude the products don't perform as advertised. That said, I've traded this many times, and that's all RWLK is: a trade, not a real company to buy and hold.

[I-Man]

Too late for me. The Insiders here at RWLK have used this as personal ATM too many times now like George Economou did to DRYS then after 10 years took that private and shareholders lost everything there...

People are just growing in NUmbers in anger to all this shit going on everywhere for too long destroying hard working citizens' monies while corrupted CEO's and their Friends make off like bandits...

[Yooo]

Consider this at the current PPS? Thoughts on the last $ raise at $3.66 per share and currently a strong balance sheet of over 60 million in cash on hand… are we a good buy today under $1.50 per share? MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel, Feb. 26, 2021 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced private placement of 10,921,502 ordinary shares and warrants to purchase up to 5,460,751 ordinary shares, at a purchase price of $3.6625 per share and associated warrant, that was priced “at-the-market” under Nasdaq rules and resulted in gross proceeds of approximately $40.0 million before the deduction of placement agent fees and expenses and estimated offering expenses payable by the Company. The warrants have a term of five and one-half years, are exercisable immediately and have an exercise price of $3.60 per ordinary share. https://finance.yahoo.com/news/rewalk-robotics-announces-closing-40-174100142.html

[I-Man]

No, none to date. I took all my monies out of this after several years invested, and placed elsewhere sadly..

[Yooo]

Any reply?

[Yooo]

IMO. This baby wants to pop and run!!